Literature DB >> 33572803

Orientation of Antigen Display on Self-Assembling Protein Nanoparticles Influences Immunogenicity.

Cosette G Schneider1,2, Justin A Taylor1,2, Michael Q Sibilo1,3, Kazutoyo Miura4, Katherine L Mallory1,3, Christopher Mann1,3, Christopher Karch5,6, Zoltan Beck5,6, Gary R Matyas5, Carole A Long4, Elke Bergmann-Leitner1, Peter Burkhard7, Evelina Angov1.   

Abstract

Self-assembling protein nanoparticles (SAPN) serve as a repetitive antigen delivery platform with high-density epitope display; however, antigen characteristics such as size and epitope presentation can influence the immunogenicity of the assembled particle and are aspects to consider for a rationally designed effective vaccine. Here, we characterize the folding and immunogenicity of heterogeneous antigen display by integrating (a) dual-stage antigen SAPN presenting the P. falciparum (Pf) merozoite surface protein 1 subunit, PfMSP119, and Pf cell-traversal protein for ookinetes and sporozoites, PfCelTOS, in addition to (b) a homogenous antigen SAPN displaying two copies of PfCelTOS. Mice and rabbits were utilized to evaluate antigen-specific humoral and cellular induction as well as functional antibodies via growth inhibition of the blood-stage parasite. We demonstrate that antigen orientation and folding influence the elicited immune response, and when appropriately designed, SAPN can serve as an adaptable platform for an effective multi-antigen display.

Entities:  

Keywords:  PfCelTOS; PfMSP119; display; multi-stage; self-assembling protein nanoparticles; vaccine

Year:  2021        PMID: 33572803      PMCID: PMC7911071          DOI: 10.3390/vaccines9020103

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  89 in total

Review 1.  Unravelling viral camouflage: approaches to the study and characterization of conformational epitopes.

Authors:  T Augustin; O Cehlar; R Skrabana; P Majerova; J Hanes
Journal:  Acta Virol       Date:  2015-06       Impact factor: 1.162

2.  Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21.

Authors:  Zoltan Beck; Gary R Matyas; Rashmi Jalah; Mangala Rao; Victoria R Polonis; Carl R Alving
Journal:  Vaccine       Date:  2015-09-13       Impact factor: 3.641

3.  Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.

Authors:  Sanjay Singh; Kazutoyo Miura; Hong Zhou; Olga Muratova; Brian Keegan; Aaron Miles; Laura B Martin; Allan J Saul; Louis H Miller; Carole A Long
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

4.  Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.

Authors:  S Kumar; A Yadava; D B Keister; J H Tian; M Ohl; K A Perdue-Greenfield; L H Miller; D C Kaslow
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

5.  Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate.

Authors:  Matthew L Plassmeyer; Karine Reiter; Richard L Shimp; Svetlana Kotova; Paul D Smith; Darrell E Hurt; Brent House; Xiaoyan Zou; Yanling Zhang; Merrit Hickman; Onyinyechukwu Uchime; Raul Herrera; Vu Nguyen; Jacqueline Glen; Jacob Lebowitz; Albert J Jin; Louis H Miller; Nicholas J MacDonald; Yimin Wu; David L Narum
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

Review 6.  Army Liposome Formulation (ALF) family of vaccine adjuvants.

Authors:  Carl R Alving; Kristina K Peachman; Gary R Matyas; Mangala Rao; Zoltan Beck
Journal:  Expert Rev Vaccines       Date:  2020-03-31       Impact factor: 5.217

7.  The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines.

Authors:  Diego A Espinosa; Joel Vega-Rodriguez; Yevel Flores-Garcia; Amy R Noe; Christian Muñoz; Russell Coleman; Torben Bruck; Keith Haney; Alex Stevens; Diane Retallack; Jeff Allen; Thomas S Vedvick; Christopher B Fox; Steven G Reed; Randall F Howard; Ahmed M Salman; Chris J Janse; Shahid M Khan; Fidel Zavala; Gabriel M Gutierrez
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

8.  Protein nanovaccine confers robust immunity against Toxoplasma.

Authors:  Kamal El Bissati; Ying Zhou; Sara Maria Paulillo; Senthil Kumar Raman; Christopher P Karch; Craig W Roberts; David E Lanar; Steve Reed; Chris Fox; Darrick Carter; Jeff Alexander; Alessandro Sette; John Sidney; Hernan Lorenzi; Ian J Begeman; Peter Burkhard; Rima McLeod
Journal:  NPJ Vaccines       Date:  2017-09-05       Impact factor: 7.344

9.  Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens.

Authors:  Geoffrey M Lynn; Christine Sedlik; Faezzah Baharom; Yaling Zhu; Ramiro A Ramirez-Valdez; Vincent L Coble; Kennedy Tobin; Sarah R Nichols; Yaakov Itzkowitz; Neeha Zaidi; Joshua M Gammon; Nicolas J Blobel; Jordan Denizeau; Philippe de la Rochere; Brian J Francica; Brennan Decker; Mateusz Maciejewski; Justin Cheung; Hidehiro Yamane; Margery G Smelkinson; Joseph R Francica; Richard Laga; Joshua D Bernstock; Leonard W Seymour; Charles G Drake; Christopher M Jewell; Olivier Lantz; Eliane Piaggio; Andrew S Ishizuka; Robert A Seder
Journal:  Nat Biotechnol       Date:  2020-01-13       Impact factor: 68.164

10.  Heterologous protein expression is enhanced by harmonizing the codon usage frequencies of the target gene with those of the expression host.

Authors:  Evelina Angov; Collette J Hillier; Randall L Kincaid; Jeffrey A Lyon
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

View more
  3 in total

Review 1.  Systems biology of malaria explored with nonhuman primates.

Authors:  Mary R Galinski
Journal:  Malar J       Date:  2022-06-07       Impact factor: 3.469

2.  Investigating the Role of Antigen Orientation on the Immune Response Elicited by Neisseria meningitidis Factor H Binding Protein on GMMA.

Authors:  Renzo Alfini; Brunella Brunelli; Erika Bartolini; Martina Carducci; Enrico Luzzi; Francesca Ferlicca; Scilla Buccato; Barbara Galli; Paola Lo Surdo; Maria Scarselli; Giacomo Romagnoli; Elena Cartocci; Domenico Maione; Silvana Savino; Francesca Necchi; Isabel Delany; Francesca Micoli
Journal:  Vaccines (Basel)       Date:  2022-07-26

3.  Novel malaria vaccines.

Authors:  Matthew B Laurens
Journal:  Hum Vaccin Immunother       Date:  2021-08-04       Impact factor: 4.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.